174 related articles for article (PubMed ID: 36843616)
1. Different sleep pattern in over-weight/obese women with polycystic ovary syndrome.
Oberg E; Blomberg L; Åkerstedt T; Hirschberg AL
Front Endocrinol (Lausanne); 2023; 14():1068045. PubMed ID: 36843616
[TBL] [Abstract][Full Text] [Related]
2. Benefit of Delayed Fertility Therapy With Preconception Weight Loss Over Immediate Therapy in Obese Women With PCOS.
Legro RS; Dodson WC; Kunselman AR; Stetter CM; Kris-Etherton PM; Williams NI; Gnatuk CL; Estes SJ; Allison KC; Sarwer DB; Diamond MP; Schlaff WD; Casson PR; Christman GM; Barnhart KT; Bates GW; Usadi R; Lucidi S; Baker V; Zhang H; Eisenberg E; Coutifaris C; Dokras A
J Clin Endocrinol Metab; 2016 Jul; 101(7):2658-66. PubMed ID: 27172435
[TBL] [Abstract][Full Text] [Related]
3. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
[TBL] [Abstract][Full Text] [Related]
4. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
[TBL] [Abstract][Full Text] [Related]
5. Psychological well-being and personality in relation to weight loss following behavioral modification intervention in obese women with polycystic ovary syndrome: a randomized controlled trial.
Oberg E; Lundell C; Blomberg L; Gidlöf SB; Egnell PT; Hirschberg AL
Eur J Endocrinol; 2020 Jul; 183(1):1-11. PubMed ID: 32503005
[TBL] [Abstract][Full Text] [Related]
6. Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trial.
Cooney LG; Milman LW; Hantsoo L; Kornfield S; Sammel MD; Allison KC; Epperson CN; Dokras A
Fertil Steril; 2018 Jul; 110(1):161-171.e1. PubMed ID: 29908771
[TBL] [Abstract][Full Text] [Related]
7. Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome.
Legro RS; Dodson WC; Kris-Etherton PM; Kunselman AR; Stetter CM; Williams NI; Gnatuk CL; Estes SJ; Fleming J; Allison KC; Sarwer DB; Coutifaris C; Dokras A
J Clin Endocrinol Metab; 2015 Nov; 100(11):4048-58. PubMed ID: 26401593
[TBL] [Abstract][Full Text] [Related]
8. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
[TBL] [Abstract][Full Text] [Related]
9. Endometrial Expression of Estrogen Receptors and the Androgen Receptor in Women With Polycystic Ovary Syndrome: A Lifestyle Intervention Study.
Hulchiy M; Nybacka Å; Sahlin L; Hirschberg AL
J Clin Endocrinol Metab; 2016 Feb; 101(2):561-71. PubMed ID: 26649621
[TBL] [Abstract][Full Text] [Related]
10. Improved menstrual function in obese women with polycystic ovary syndrome after behavioural modification intervention-A randomized controlled trial.
Oberg E; Gidlöf S; Jakson I; Mitsell M; Tollet Egnell P; Hirschberg AL
Clin Endocrinol (Oxf); 2019 Mar; 90(3):468-478. PubMed ID: 30565716
[TBL] [Abstract][Full Text] [Related]
11. A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial.
Jiskoot G; Benneheij SH; Beerthuizen A; de Niet JE; de Klerk C; Timman R; Busschbach JJ; Laven JS
Reprod Health; 2017 Mar; 14(1):34. PubMed ID: 28264692
[TBL] [Abstract][Full Text] [Related]
12. Lifestyle modification intervention among infertile overweight and obese women with polycystic ovary syndrome.
Mahoney D
J Am Assoc Nurse Pract; 2014 Jun; 26(6):301-8. PubMed ID: 24170708
[TBL] [Abstract][Full Text] [Related]
13. Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study.
Ollila MM; West S; Keinänen-Kiukaanniemi S; Jokelainen J; Auvinen J; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Franks S; Piltonen TT; Morin-Papunen LC
Hum Reprod; 2017 Feb; 32(2):423-431. PubMed ID: 28031324
[TBL] [Abstract][Full Text] [Related]
14. Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome.
Scott D; Harrison CL; Hutchison S; de Courten B; Stepto NK
PLoS One; 2017; 12(8):e0182412. PubMed ID: 28771628
[TBL] [Abstract][Full Text] [Related]
15. Effect of Lifestyle Intervention on Cardiometabolic Risk Factors in Overweight and Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
Khatlani K; Njike V; Costales VC
Metab Syndr Relat Disord; 2019 Dec; 17(10):473-485. PubMed ID: 31513475
[TBL] [Abstract][Full Text] [Related]
16. Lifestyle Intervention for Overweight/Obese Pregnant Women with Polycystic Ovarian Syndrome: Lessons and Challenges.
Liu C; Zhang L; Zheng W; Liang X; Zhang L; Tian Z; Li G
Obes Facts; 2021; 14(4):405-414. PubMed ID: 34311460
[TBL] [Abstract][Full Text] [Related]
17. Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.
Panidis D; Tziomalos K; Papadakis E; Vosnakis C; Chatzis P; Katsikis I
Endocrine; 2013 Dec; 44(3):583-90. PubMed ID: 23625194
[TBL] [Abstract][Full Text] [Related]
18. Does a restricted energy low glycemic index diet have a different effect on overweight women with or without polycystic ovary syndrome?
Shishehgar F; Mirmiran P; Rahmati M; Tohidi M; Ramezani Tehrani F
BMC Endocr Disord; 2019 Sep; 19(1):93. PubMed ID: 31477085
[TBL] [Abstract][Full Text] [Related]
19. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.
Hutchison SK; Stepto NK; Harrison CL; Moran LJ; Strauss BJ; Teede HJ
J Clin Endocrinol Metab; 2011 Jan; 96(1):E48-56. PubMed ID: 20926534
[TBL] [Abstract][Full Text] [Related]
20. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.
Panidis D; Tziomalos K; Papadakis E; Chatzis P; Kandaraki EA; Tsourdi EA; Katsikis I
Clin Endocrinol (Oxf); 2014 Mar; 80(3):432-8. PubMed ID: 23909452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
